Bank of Marin’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-868
Closed -$205K 132
2020
Q4
$205K Buy
868
+49
+6% +$11.2K 0.17% 128
2020
Q3
$223K Buy
819
+65
+9% +$17.9K 0.23% 110
2020
Q2
$219K Buy
+754
New +$204K 0.25% 109

Other funds holding VRTX

Bank of Marin's VRTX Position: Q1 2021 in Review

Bank of Marin sold out of Vertex Pharmaceuticals (VRTX) in Q1 2021, closing a stake of 868 shares — an estimated $205K sold.

Bank of Marin first reported a position in VRTX in Q2 2020 and held it in 3 quarters. The position peaked at $223K in Q3 2020. 1,000 funds tracked by Wall St. Rank hold VRTX as of Q1 2021.

  • Bank of Marin reported no remaining Vertex Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Bank of Marin sold 868 Vertex Pharmaceuticals shares in Q1 2021, an estimated $205K.
  • Bank of Marin first reported a position in Vertex Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Bank of Marin's Vertex Pharmaceuticals position peaked at $223K in Q3 2020.
  • 1,000 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2021.

Based on Bank of Marin's 13F filing for Q1 2021, filed 4 May 2021.